GlycoMimetics (GLYC) Tops Q1 EPS by 3c; Reports Cash and Cash Equivalents of $76.5M

GlycoMimetics (NASDAQ: GLYC) reported Q1 EPS of ($0.28), $0.03 better than the analyst estimate of ($0.31). Cash and cash equivalents at March 31, 2022 were $76.5 million.

For earnings history and earnings-related data on GlycoMimetics (GLYC) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Creatd files Form S-1 and reports Q1 2026 financial results
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus